Molecular Weight: 557.04 g/mol
Chemical Structure
Check the
Neratinib (HKI-272)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
7 mg/mL
(12.56 mM)
; Warmed with 60°C water bath
; Ultrasonicated
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
5 mg/mL
(8.97 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.) |
| Ethanol | 2 mg/mL |
| Water | Insoluble |
| DMSO |
5 mg/mL
(8.97 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
Pre-aliquoted for Longevity: Solid-state aliquots offer significantly longer shelf life compared to stock solutions, ensuring maximum stability for every use.
Looking for a specific aliquot size? Reach out to your local sales representative or contact us at orders@selleckchem.com.
| IUPAC Name | (E)-N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide | |
|---|---|---|
| CAS Number | 698387-09-6 | |
| Molecular Formula |
C30H29ClN6O3 |
|
| Molecular Weight (MW) | 557.04 | |
| SMILES | CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C | |
| InChIKey | JWNPDZNEKVCWMY-VQHVLOKHSA-N |
- Neratinib (HKI-272) Mechanism of Action: HER2 Inhibition in Breast Cancer Cell Research
- Neratinib (HKI-272) Clinical Trials
- Neratinib (HKI-272): Selectivity & Specificity
- Neratinib (HKI-272) Working Concentration | Cell Culture | Treatment
- Neratinib (HKI-272) Solubility in DMSO
- Neratinib (HKI-272) Stock Solution
- Neratinib (HKI-272) Storage
- Neratinib (HKI-272) Stability
- Neratinib (HKI-272) Combination Database
- Neratinib (HKI-272) SMILES
- Neratinib (HKI-272) CAS Number
- Neratinib (HKI-272) Chemical Structure (2D and 3D)
- Neratinib (HKI-272) IC50 for Cell-based and Cell-free Assays
- Neratinib (HKI-272) Cayman (18404)? Try a better option.
- Neratinib (HKI-272) MedChemExpress (HY-32721)? Try a better option.
- Neratinib (HKI-272) Sigma (SML4231)? Try a better option.
- Neratinib (HKI-272) APExBIO (A8322)? Try a better option.
- Neratinib (HKI-272) SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.